Nellis Smith, MD
Cardiovascular Disease (Cardiology) · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 4 carriers
- Offices
- 7
Offices
7 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center · Sequoia Hospital. That is not proof they admit you there this week.
Plans that list them
17 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Smith’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C40443 · Current
Licensed to practise in California · since 1982 · expires 2027-09-30 · University of Texas Medical Branch at Galveston.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$364,921
Medicare paid this office $364,921 for 1,497 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 423 | $104,875 | $156 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 21 | $31,327 | $1,492 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 162 | $29,497 | $178 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 92 | $24,825 | $104 |
| Interpretation and report of ultrasound of heart | 241 | $19,061 | $76 |
See all 38 services
| Long return visit (40+ min) | 423 | $104,875 | $156 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 21 | $31,327 | $1,492 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 162 | $29,497 | $178 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 92 | $24,825 | $104 |
| Interpretation and report of ultrasound of heart | 241 | $19,061 | $76 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 21 | $17,228 | $410 |
| Ultrasound of both sides of head and neck blood flow | 71 | $13,755 | $191 |
| New patient visit (60+ min) | 55 | $9,937 | $181 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 155 | $9,055 | $58 |
| Return visit (30+ min) | 67 | $8,999 | $115 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 38 | $8,627 | $227 |
| Ct scan of blood vessels and grafts of heart with contrast | 90 | $8,429 | $94 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 306 | $7,291 | $13 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $7,149 | $149 |
| Programming of dual lead pacemaker system | 42 | $5,349 | $78 |
| Ultrasound of heart blood flow, valves and chambers | 238 | $3,946 | $16 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 191 | $3,241 | $15 |
| External shock to heart to regulate heart beat | 33 | $3,175 | $91 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $2,885 | $57 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 52 | $2,759 | $20 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 47 | $2,635 | $23 |
| Ultrasound of heart with probe in esophagus, with report | 29 | $2,530 | $87 |
| Ultrasound of heart, follow-up | 16 | $2,091 | $105 |
| Ultrasound of heart, follow-up | 90 | $2,026 | $21 |
| Aspiration of fluid from chest cavity using imaging guidance | 16 | $1,923 | $92 |
| Programming of multiple lead pacemaker system | 11 | $1,769 | $80 |
| Long return visit (40+ min) | 16 | $1,720 | $108 |
| Return visit (30+ min) | 19 | $1,660 | $87 |
| Mri scan of heart before and after contrast | 15 | $1,525 | $102 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 21 | $1,483 | $71 |
| 3d radiographic procedure | 53 | $1,386 | $25 |
| Ct scan of heart with evaluation of blood vessel calcium | 54 | $1,181 | $22 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 42 | $993 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 256 | $736 | $3 |
| Injection, regadenoson, 0.1 mg | 22 | $667 | None |
| Heart rhythm recording of continous external ekg over 8-15 days | 41 | $547 | $12 |
| Heart muscle strain imaging | 12 | $504 | $39 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 29 | $181 | $6 |
Procedures Medicare counted
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
1,497 Original Medicare patients in 2024. Average age 77 · Under 65 2% · 85 and older 20% · Women 45% · Also on Medicaid 4% · Health risk score 1.21. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Atrial fibrillation 59% · Coronary heart disease 40% · Heart failure 27% · Chronic kidney disease 25% · Diabetes 24% · Cancer 16% · COPD 12% · Depression 12% · Stroke 8% · Dementia 6%.
The office billed $1,725,109, Medicare allowed $486,129 and paid $364,921; for 4,451 services of 77 kinds; $667 of it was for drugs given in the office and $364,254 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,497 | 4,451 | 77 | 1.21 | $1,725,109 | $364,921 |
| 2023 | 1,418 | 4,153 | 78 | 1.22 | $1,677,308 | $359,842 |
| 2022 | 1,361 | 4,336 | 77 | 1.16 | $1,727,937 | $396,338 |
| 2021 | 1,167 | 4,146 | 77 | 1.19 | $1,495,939 | $375,387 |
| 2020 | 878 | 4,208 | 77 | 1.37 | $1,385,919 | $337,713 |
| 2019 | 875 | 4,434 | 77 | 1.35 | $1,446,094 | $326,956 |
| 2018 | 864 | 3,960 | 77 | 1.40 | $1,098,701 | $257,594 |
| 2017 | 919 | 3,745 | 78 | 1.37 | $1,206,264 | $282,469 |
| 2016 | 806 | 3,579 | 78 | 1.38 | $1,140,630 | $268,060 |
| 2015 | 743 | 3,884 | 78 | 1.46 | $1,298,749 | $326,161 |
| 2014 | 571 | 3,046 | 78 | 1.56 | $945,707 | $283,406 |
| 2013 | 631 | 3,439 | 78 | 1.57 | $1,149,008 | $329,616 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 42 services
| Long return visit (40+ min) | 390 | $96,972 | $156 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 23 | $35,498 | $1,543 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 119 | $22,153 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 88 | $21,806 | $108 |
| Interpretation and report of ultrasound of heart | 240 | $19,480 | $79 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 23 | $19,201 | $417 |
| Ultrasound of both sides of head and neck blood flow | 85 | $16,123 | $187 |
| New patient visit (60+ min) | 58 | $11,116 | $192 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 153 | $9,257 | $60 |
| Return visit (30+ min) | 75 | $8,262 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,243 | $154 |
| Programming of dual lead pacemaker system | 49 | $6,758 | $79 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 287 | $6,620 | $13 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 31 | $6,424 | $207 |
| Ct scan of heart structure with contrast | 77 | $5,638 | $73 |
| Injection, regadenoson, 0.1 mg | 23 | $3,854 | None |
| Return visit (30+ min) | 44 | $3,808 | $87 |
| Ultrasound of heart blood flow, valves and chambers | 224 | $3,701 | $16 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 12 | $3,238 | $59 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 55 | $2,997 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 49 | $2,794 | $23 |
| Ct scan of blood vessels and grafts of heart with contrast | 23 | $2,593 | $104 |
| Programming of multiple lead pacemaker system | 14 | $2,310 | $86 |
| Aspiration of fluid from chest cavity using imaging guidance | 12 | $2,034 | $102 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,896 | $105 |
| Ultrasound of heart, follow-up | 17 | $1,882 | $94 |
| Ultrasound of heart, follow-up | 64 | $1,715 | $22 |
| Emergency department visit with high level of medical decision making | 11 | $1,676 | $152 |
| External shock to heart to regulate heart beat | 15 | $1,584 | $99 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 23 | $1,519 | $66 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $1,444 | $96 |
| Short return visit (20+ min) | 21 | $1,353 | $61 |
| Ct scan of heart with evaluation of blood vessel calcium | 57 | $1,318 | $23 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 41 | $911 | $22 |
| 3d radiographic procedure | 33 | $809 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 248 | $722 | $3 |
| Heart rhythm recording of continous external ekg over 8-15 days | 41 | $521 | $12 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 14 | $379 | $24 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 17 | $362 | $21 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $361 | $23 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 17 | $218 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 33 | $218 | $6 |
2022: 43 services
| Long return visit (40+ min) | 370 | $91,211 | $156 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 33 | $50,988 | $1,545 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 163 | $32,807 | $194 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 33 | $27,492 | $417 |
| Interpretation and report of ultrasound of heart | 247 | $19,687 | $78 |
| Return visit (30+ min) | 127 | $17,694 | $107 |
| Ultrasound of both sides of head and neck blood flow | 89 | $16,884 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 78 | $15,537 | $91 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 40 | $9,221 | $231 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $8,976 | $180 |
| New patient visit (60+ min) | 43 | $8,394 | $195 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 125 | $8,266 | $63 |
| Programming of dual lead pacemaker system | 51 | $8,021 | $81 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 309 | $6,208 | $13 |
| Injection, regadenoson, 0.1 mg | 31 | $5,997 | None |
| Ultrasound of heart blood flow, valves and chambers | 246 | $4,029 | $16 |
| Ct scan of blood vessels and grafts of heart with contrast | 37 | $3,544 | $96 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 60 | $3,017 | $22 |
| Programming of multiple lead pacemaker system | 12 | $2,704 | $84 |
| Hospital discharge day management, more than 30 minutes | 27 | $2,696 | $96 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 51 | $2,638 | $24 |
| Short return visit (20+ min) | 30 | $2,345 | $76 |
| Ct scan of heart structure with contrast | 31 | $2,216 | $71 |
| External shock to heart to regulate heart beat | 20 | $1,989 | $99 |
| Ultrasound of heart, follow-up | 18 | $1,860 | $89 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 18 | $1,756 | $23 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,563 | $98 |
| Return visit (30+ min) | 17 | $1,512 | $89 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 21 | $1,441 | $69 |
| Aspiration of fluid from chest cavity using imaging guidance | 11 | $1,277 | $98 |
| 3d radiographic procedure | 49 | $1,157 | $23 |
| Ct scan of heart with evaluation of blood vessel calcium | 46 | $1,010 | $22 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 38 | $887 | $23 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $859 | $21 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 32 | $784 | $24 |
| Ultrasound of heart, follow-up | 31 | $752 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 254 | $725 | $3 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $711 | $26 |
| Heart muscle strain imaging | 13 | $673 | $40 |
| Heart rhythm recording of continous external ekg over 8-15 days | 38 | $549 | $14 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 18 | $509 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $489 | $23 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 14 | $91 | $6 |
2021: 37 services
| Long return visit (40+ min) | 314 | $81,137 | $163 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 32 | $51,261 | $1,602 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 143 | $29,975 | $201 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 32 | $26,873 | $420 |
| Interpretation and report of ultrasound of heart | 282 | $23,756 | $81 |
| Return visit (30+ min) | 177 | $22,479 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 76 | $13,984 | $93 |
| Ultrasound of both sides of head and neck blood flow | 56 | $10,586 | $189 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $10,023 | $179 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 38 | $9,251 | $243 |
| Ct scan of blood vessels and grafts of heart with contrast | 75 | $8,063 | $105 |
| Programming of dual lead pacemaker system | 48 | $6,909 | $78 |
| New patient visit (60+ min) | 36 | $6,769 | $188 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 100 | $6,625 | $64 |
| Injection, regadenoson, 0.1 mg | 34 | $6,467 | None |
| Ultrasound of heart blood flow, valves and chambers | 290 | $4,992 | $16 |
| Short return visit (20+ min) | 51 | $4,340 | $79 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 195 | $3,784 | $14 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 56 | $3,188 | $23 |
| Hospital discharge day management, more than 30 minutes | 26 | $2,678 | $99 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 46 | $2,353 | $23 |
| Programming of multiple lead pacemaker system | 11 | $2,212 | $82 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 30 | $2,003 | $67 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,675 | $99 |
| 3d radiographic procedure with computerized image postprocessing | 22 | $1,632 | $71 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 16 | $1,584 | $22 |
| Ultrasound of heart, follow-up | 13 | $1,531 | $102 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,394 | $93 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 40 | $966 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 14 | $891 | $56 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 291 | $879 | $3 |
| Ct scan of heart with evaluation of blood vessel calcium | 32 | $804 | $24 |
| Ultrasound of heart, follow-up | 24 | $668 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 41 | $637 | $15 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 12 | $390 | $28 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $375 | $27 |
| 3d radiographic procedure | 15 | $342 | $23 |
2020: 43 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 33 | $55,212 | $1,624 |
| Return visit (30+ min) | 241 | $34,457 | $94 |
| Long return visit (40+ min) | 150 | $28,748 | $133 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 33 | $28,381 | $417 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 118 | $25,647 | $205 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $18,796 | $95 |
| Interpretation and report of ultrasound of heart | 195 | $17,080 | $82 |
| Ultrasound of both sides of head and neck blood flow | 54 | $10,815 | $197 |
| Short return visit (20+ min) | 111 | $8,450 | $63 |
| Telephone medical discussion with physician, 21-30 minutes | 63 | $8,323 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $7,466 | $187 |
| Ct scan of blood vessels and grafts of heart with contrast | 61 | $6,797 | $110 |
| Injection, regadenoson, 0.1 mg | 34 | $6,541 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 262 | $6,280 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 91 | $6,271 | $67 |
| Programming of dual lead pacemaker system | 38 | $4,638 | $67 |
| New patient visit (60+ min) | 22 | $4,036 | $183 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 17 | $3,657 | $215 |
| Ultrasound of heart blood flow, valves and chambers | 196 | $3,556 | $17 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 55 | $2,944 | $25 |
| Ultrasound of heart, follow-up | 18 | $2,657 | $98 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 34 | $2,389 | $68 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 44 | $2,314 | $26 |
| Hospital discharge day management, more than 30 minutes | 18 | $2,296 | $100 |
| Programming of multiple lead pacemaker system | 13 | $2,093 | $75 |
| New patient visit (45+ min) | 13 | $2,010 | $155 |
| Aspiration of fluid from chest cavity using imaging guidance | 12 | $1,966 | $116 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 17 | $1,568 | $24 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 68 | $1,514 | $6 |
| Anticoagulant management of patient taking warfarin | 11 | $1,511 | $10 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,454 | $66 |
| External ekg recording for more than 48 hours up to 21 days | 37 | $1,119 | $27 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $1,050 | $70 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 37 | $1,005 | $24 |
| 3d radiographic procedure | 36 | $925 | $23 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $810 | $27 |
| Short return visit | 17 | $805 | $42 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $784 | $26 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 18 | $735 | $27 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 13 | $688 | $19 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 197 | $622 | $3 |
| Ct scan of heart with evaluation of blood vessel calcium | 24 | $616 | $26 |
| Ultrasound of heart, follow-up | 17 | $453 | $24 |
2019: 46 services
| Return visit (30+ min) | 281 | $40,970 | $96 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 23 | $35,336 | $1,536 |
| Long return visit (40+ min) | 191 | $33,119 | $131 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 85 | $19,679 | $93 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 24 | $19,549 | $416 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 97 | $19,496 | $195 |
| Ultrasound of both sides of head and neck blood flow | 77 | $15,352 | $199 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 49 | $11,304 | $226 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 363 | $10,261 | $16 |
| Ct scan of blood vessels and grafts of heart with contrast | 90 | $9,692 | $107 |
| Interpretation and report of ultrasound of heart | 106 | $8,901 | $81 |
| Short return visit (20+ min) | 121 | $8,510 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,886 | $179 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 88 | $5,984 | $67 |
| Programming of dual lead pacemaker system | 45 | $4,920 | $59 |
| Injection, regadenoson, 0.1 mg | 25 | $4,607 | None |
| New patient visit (60+ min) | 24 | $4,391 | $183 |
| New patient visit (45+ min) | 30 | $4,105 | $137 |
| Anticoagulant management of patient taking warfarin | 13 | $3,069 | $10 |
| Ultrasound of heart, follow-up | 23 | $2,739 | $88 |
| Ultrasound of heart blood flow, valves and chambers | 45 | $2,512 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,207 | $61 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 68 | $1,991 | $26 |
| Ultrasound of heart blood flow, valves and chambers | 104 | $1,787 | $17 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 109 | $1,748 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 25 | $1,738 | $70 |
| Aspiration of fluid from chest cavity using imaging guidance | 12 | $1,675 | $112 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 27 | $1,653 | $25 |
| 3d radiographic procedure | 68 | $1,644 | $23 |
| External shock to heart to regulate heart beat | 15 | $1,520 | $101 |
| Hospital discharge day management, more than 30 minutes | 15 | $1,476 | $98 |
| Short return visit | 30 | $1,224 | $36 |
| External ekg recording for more than 48 hours up to 21 days | 41 | $1,142 | $27 |
| Programming of single lead pacemaker system | 13 | $1,107 | $48 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 18 | $1,061 | $26 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 41 | $1,022 | $24 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $1,011 | $22 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 12 | $991 | $83 |
| Hospital observation care on day of discharge | 12 | $781 | $65 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 23 | $760 | $25 |
| Evaluation of implantable heart and blood vessel monitoring system | 14 | $759 | $36 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 13 | $697 | $12 |
| Ct scan of heart with evaluation of blood vessel calcium | 26 | $658 | $25 |
| Ultrasound of heart, follow-up | 21 | $564 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 12 | $399 | $33 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 104 | $312 | $3 |
2018: 43 services
| Return visit (30+ min) | 307 | $43,287 | $90 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 12 | $18,131 | $1,511 |
| Ultrasound of both sides of head and neck blood flow | 79 | $16,279 | $206 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 84 | $15,959 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 82 | $13,989 | $93 |
| Long return visit (40+ min) | 86 | $13,464 | $127 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 12 | $9,798 | $408 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 43 | $9,511 | $221 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 339 | $9,508 | $15 |
| Short return visit (20+ min) | 120 | $9,280 | $61 |
| Interpretation and report of ultrasound of heart | 100 | $8,379 | $79 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $7,652 | $174 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 103 | $6,777 | $65 |
| New patient visit (45+ min) | 48 | $6,467 | $135 |
| Ct scan of blood vessels and grafts of heart with contrast | 61 | $6,340 | $101 |
| Programming of dual lead pacemaker system | 48 | $4,974 | $52 |
| Anticoagulant management of patient taking warfarin | 17 | $3,938 | $11 |
| Ultrasound of heart, follow-up | 21 | $2,800 | $104 |
| New patient visit (60+ min) | 13 | $2,383 | $183 |
| Ultrasound of heart blood flow, valves and chambers | 41 | $2,241 | $55 |
| Injection, regadenoson, 0.1 mg | 13 | $2,182 | None |
| Short return visit | 43 | $2,043 | $40 |
| Initial hospital observation care per day, typically 70 minutes | 11 | $1,821 | $166 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 62 | $1,814 | $27 |
| Ultrasound of heart blood flow, valves and chambers | 105 | $1,808 | $16 |
| Programming of multiple lead pacemaker system | 11 | $1,705 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,682 | $65 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 123 | $1,380 | $6 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 24 | $1,278 | $26 |
| External shock to heart to regulate heart beat | 12 | $1,197 | $100 |
| Aspiration of fluid from chest cavity using imaging guidance | 11 | $1,113 | $93 |
| 3d radiographic procedure | 48 | $1,092 | $23 |
| External ekg recording for more than 48 hours up to 21 days | 37 | $1,011 | $26 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 37 | $922 | $24 |
| Return visit (30+ min) | 13 | $908 | $70 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 14 | $905 | $65 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 16 | $791 | $26 |
| Programming of single lead pacemaker system | 15 | $790 | $44 |
| Ct scan of heart with evaluation of blood vessel calcium | 31 | $765 | $25 |
| Hospital discharge day management, 30 minutes or less | 11 | $727 | $66 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 21 | $724 | $27 |
| Ultrasound of heart, follow-up | 15 | $346 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 106 | $317 | $3 |
2017: 43 services
| Return visit (30+ min) | 293 | $39,330 | $90 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 19 | $28,081 | $1,478 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 118 | $24,273 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 81 | $19,266 | $227 |
| Ultrasound of both sides of head and neck blood flow | 73 | $14,457 | $195 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 49 | $13,294 | $266 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $12,885 | $179 |
| Interpretation and report of ultrasound of heart | 150 | $12,694 | $80 |
| Short return visit (20+ min) | 128 | $9,356 | $58 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 20 | $9,250 | $231 |
| Long return visit (40+ min) | 56 | $8,090 | $123 |
| Ct scan of blood vessels and grafts of heart with contrast | 62 | $6,605 | $105 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 113 | $6,523 | $57 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 222 | $5,711 | $16 |
| 3d radiographic procedure with computerized image postprocessing | 71 | $4,905 | $68 |
| Programming of dual lead pacemaker system | 49 | $4,359 | $51 |
| Injection, regadenoson, 0.1 mg | 21 | $3,645 | None |
| Ultrasound of heart, follow-up | 16 | $3,283 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $3,157 | $64 |
| Aspiration of fluid from chest cavity using imaging guidance | 14 | $2,980 | $115 |
| New patient visit (45+ min) | 17 | $2,573 | $151 |
| Ultrasound of heart blood flow, valves and chambers | 147 | $2,567 | $17 |
| Ultrasound of heart blood flow, valves and chambers | 43 | $2,387 | $54 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 172 | $2,351 | $6 |
| Initial hospital observation care per day, typically 70 minutes | 11 | $1,823 | $166 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 23 | $1,719 | $75 |
| New patient visit (30+ min) | 18 | $1,716 | $95 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,661 | $98 |
| Programming of dual lead implantable defibrillator system | 13 | $1,607 | $70 |
| Mri scan of heart without contrast | 15 | $1,561 | $104 |
| External shock to heart to regulate heart beat | 13 | $1,503 | $100 |
| Hospital discharge day management, 30 minutes or less | 21 | $1,450 | $66 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 43 | $1,164 | $26 |
| Short return visit | 34 | $1,123 | $31 |
| Hospital observation care on day of discharge | 14 | $924 | $66 |
| Short return visit (20+ min) | 18 | $863 | $45 |
| Ultrasound of heart, follow-up | 31 | $810 | $23 |
| 3d radiographic procedure | 30 | $736 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 13 | $622 | $27 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 147 | $446 | $3 |
| External ekg recording for more than 48 hours up to 21 days | 15 | $423 | $28 |
| Ct scan of heart with evaluation of blood vessel calcium | 15 | $389 | $26 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 15 | $365 | $24 |
2016: 46 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 23 | $34,946 | $1,456 |
| Return visit (30+ min) | 251 | $32,243 | $87 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 90 | $20,981 | $228 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 88 | $17,250 | $91 |
| Short return visit (20+ min) | 146 | $12,031 | $60 |
| Interpretation and report of ultrasound of heart | 124 | $11,661 | $88 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 23 | $10,872 | $227 |
| Ultrasound of both sides of head and neck blood flow | 54 | $10,096 | $184 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 34 | $8,970 | $264 |
| Long return visit (40+ min) | 62 | $8,816 | $130 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $8,131 | $177 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 288 | $7,087 | $15 |
| 3d radiographic procedure with computerized image postprocessing | 78 | $5,383 | $67 |
| Programming of dual lead pacemaker system | 47 | $4,625 | $52 |
| New patient visit (45+ min) | 31 | $4,105 | $132 |
| Injection, regadenoson, 0.1 mg | 23 | $4,058 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 69 | $3,968 | $56 |
| New patient visit (30+ min) | 39 | $3,419 | $88 |
| Ct scan of blood vessels and grafts of heart with contrast | 32 | $3,324 | $104 |
| Ultrasound of heart, follow-up | 20 | $2,781 | $126 |
| Short return visit | 55 | $2,529 | $40 |
| Ultrasound of heart blood flow, valves and chambers | 131 | $2,239 | $16 |
| Programming of dual lead implantable defibrillator system | 20 | $2,117 | $73 |
| Initial hospital observation care per day, typically 70 minutes | 13 | $2,106 | $162 |
| New patient visit (60+ min) | 11 | $2,051 | $186 |
| External shock to heart to regulate heart beat | 14 | $1,967 | $109 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 26 | $1,879 | $70 |
| Programming of multiple lead implantable defibrillator system | 11 | $1,813 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,765 | $63 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 121 | $1,678 | $6 |
| Programming of multiple lead pacemaker system | 11 | $1,636 | $63 |
| Hospital discharge day management, 30 minutes or less | 24 | $1,615 | $65 |
| Ultrasound of heart blood flow, valves and chambers | 30 | $1,587 | $53 |
| Mri scan of heart without contrast | 14 | $1,535 | $102 |
| Aspiration of fluid from chest cavity using imaging guidance | 12 | $1,487 | $99 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,036 | $94 |
| Programming of single lead pacemaker system | 13 | $819 | $43 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 31 | $802 | $26 |
| Evaluation of implantable heart and blood vessel monitoring system | 20 | $768 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 13 | $707 | $26 |
| External ekg recording for more than 48 hours up to 21 days | 27 | $695 | $26 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 27 | $637 | $24 |
| Ct scan of heart with evaluation of blood vessel calcium | 23 | $586 | $25 |
| 3d radiographic procedure | 25 | $560 | $22 |
| Ultrasound of heart, follow-up | 22 | $501 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 133 | $396 | $3 |
2015: 44 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 37 | $56,702 | $1,532 |
| Return visit (30+ min) | 230 | $34,939 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 111 | $25,670 | $98 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 94 | $23,189 | $244 |
| Short return visit (20+ min) | 200 | $20,519 | $65 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 37 | $17,321 | $241 |
| Ultrasound of both sides of head and neck blood flow | 70 | $14,287 | $201 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $11,961 | $190 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 36 | $9,984 | $277 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 284 | $9,155 | $17 |
| Interpretation and report of ultrasound of heart | 79 | $7,476 | $93 |
| Injection, regadenoson, 0.1 mg | 38 | $6,186 | None |
| Critical care, first 30-74 minutes | 13 | $5,759 | $206 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $5,364 | $68 |
| Programming of dual lead pacemaker system | 43 | $5,163 | $54 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 61 | $3,702 | $60 |
| Ultrasound of heart with probe in esophagus, with report | 28 | $3,199 | $114 |
| New patient visit (30+ min) | 34 | $3,140 | $92 |
| Ct scan of blood vessels and grafts of heart with contrast | 29 | $3,119 | $108 |
| Programming of multiple lead implantable defibrillator system | 13 | $3,083 | $88 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 38 | $2,948 | $78 |
| Ultrasound of heart, follow-up | 16 | $2,842 | $135 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 160 | $2,702 | $7 |
| Short return visit | 57 | $2,607 | $43 |
| External shock to heart to regulate heart beat | 18 | $2,452 | $117 |
| 3d radiographic procedure with computerized image postprocessing | 34 | $2,200 | $65 |
| New patient visit (45+ min) | 15 | $1,990 | $133 |
| Long return visit (40+ min) | 13 | $1,984 | $142 |
| Hospital discharge day management, more than 30 minutes | 19 | $1,950 | $103 |
| Ultrasound of heart blood flow, valves and chambers | 33 | $1,925 | $58 |
| Aspiration of fluid from chest cavity using imaging guidance | 11 | $1,613 | $101 |
| Ultrasound of heart blood flow, valves and chambers | 91 | $1,607 | $17 |
| Hospital discharge day management, 30 minutes or less | 21 | $1,465 | $70 |
| 3d radiographic procedure | 59 | $1,438 | $24 |
| Programming of dual lead implantable defibrillator system | 12 | $1,252 | $78 |
| Programming of multiple lead pacemaker system | 11 | $1,205 | $67 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 33 | $949 | $29 |
| Evaluation of implantable heart and blood vessel monitoring system | 19 | $849 | $28 |
| External ekg recording for more than 48 hours up to 21 days | 19 | $568 | $28 |
| Ct scan of heart with evaluation of blood vessel calcium | 21 | $550 | $26 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 19 | $507 | $25 |
| Ultrasound of heart, follow-up | 18 | $456 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 91 | $291 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $83 | $7 |
2014: 40 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 27 | $39,996 | $1,481 |
| Return visit (30+ min) | 230 | $32,727 | $90 |
| Long return visit (40+ min) | 173 | $29,924 | $122 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 91 | $21,358 | $230 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 78 | $15,540 | $93 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 20 | $13,948 | $697 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 27 | $12,357 | $229 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 41 | $11,592 | $283 |
| Ultrasound of both sides of head and neck blood flow | 51 | $9,593 | $188 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 270 | $8,025 | $15 |
| Short return visit (20+ min) | 99 | $7,940 | $66 |
| Programming of dual lead pacemaker system | 55 | $6,467 | $54 |
| New patient visit (45+ min) | 39 | $5,722 | $147 |
| Injection, regadenoson, 0.1 mg | 27 | $4,485 | None |
| 3d radiographic procedure with computerized image postprocessing | 53 | $4,424 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,321 | $180 |
| New patient visit (60+ min) | 21 | $3,737 | $178 |
| Programming of multiple lead implantable defibrillator system | 16 | $3,425 | $84 |
| Ct scan of blood vessels and grafts of heart with contrast | 25 | $2,637 | $105 |
| Ultrasound of heart, follow-up | 16 | $2,438 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,244 | $64 |
| Ultrasound of heart blood flow, valves and chambers | 39 | $2,145 | $55 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 27 | $1,956 | $72 |
| Programming of dual lead implantable defibrillator system | 13 | $1,887 | $75 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 13 | $1,587 | $55 |
| Evaluation of implantable heart and blood vessel monitoring system | 24 | $1,429 | $26 |
| 3d radiographic procedure | 47 | $1,416 | $29 |
| Aspiration of fluid from chest cavity using imaging guidance | 11 | $1,317 | $101 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,258 | $97 |
| New patient visit (30+ min) | 15 | $1,211 | $81 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 20 | $1,148 | $57 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 41 | $1,102 | $27 |
| Hospital discharge day management, 30 minutes or less | 15 | $984 | $66 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 17 | $901 | $26 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 56 | $730 | $6 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 12 | $500 | $33 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $482 | $30 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 19 | $444 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $315 | $17 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $57 | $3 |
2013: 42 services
| Long return visit (40+ min) | 237 | $43,894 | $124 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 31 | $36,405 | $1,174 |
| Return visit (30+ min) | 238 | $35,146 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 111 | $22,358 | $188 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 25 | $19,604 | $784 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $18,365 | $90 |
| Ultrasound of both sides of head and neck blood flow | 77 | $15,106 | $186 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 31 | $13,849 | $227 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 299 | $8,976 | $17 |
| Critical care, first 30-74 minutes | 25 | $7,622 | $186 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 32 | $7,433 | $232 |
| New patient visit (45+ min) | 47 | $6,950 | $148 |
| 3d radiographic procedure with computerized image postprocessing | 77 | $6,682 | $81 |
| Programming of dual lead pacemaker system | 61 | $5,736 | $50 |
| Injection, regadenoson, 0.1 mg | 33 | $5,355 | None |
| New patient visit (60+ min) | 29 | $5,072 | $175 |
| Short return visit (20+ min) | 60 | $4,745 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,690 | $176 |
| Programming of multiple lead implantable defibrillator system | 20 | $3,664 | $80 |
| Removal and replacement of dual lead permanent pacemaker | 11 | $3,476 | $316 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $3,194 | $63 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 33 | $2,492 | $76 |
| External shock to heart to regulate heart beat | 20 | $2,275 | $103 |
| 3d radiographic procedure | 36 | $2,241 | $62 |
| Ultrasound of heart with probe in esophagus, with report | 20 | $2,088 | $91 |
| Aspiration of fluid from chest cavity using imaging guidance | 12 | $1,875 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 29 | $1,754 | $55 |
| Ct scan of blood vessels and grafts of heart with contrast | 17 | $1,720 | $101 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $1,584 | $51 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,520 | $95 |
| Evaluation of implantable heart and blood vessel monitoring system | 27 | $1,418 | $25 |
| Ultrasound of heart, follow-up | 13 | $1,412 | $101 |
| Ultrasound of heart blood flow, valves and chambers | 31 | $1,381 | $45 |
| Hospital discharge day management, 30 minutes or less | 18 | $1,220 | $64 |
| Programming of single lead pacemaker system | 14 | $1,010 | $46 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 72 | $882 | $6 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 14 | $849 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 11 | $658 | $35 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 31 | $633 | $20 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 26 | $578 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 21 | $383 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $78 | $3 |
Drugs they prescribed that Part D paid
$798,990
Pharmacies billed $798,990 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 4,819) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
4,157 generic and 662 brand-name prescriptions · $798,990 in drug cost · 23 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 410 | $544,142 | $1,327 |
| Repatha Sureclick | 79 | $78,594 | $995 |
| Jardiance | 33 | $33,571 | $1,017 |
| Xarelto | 27 | $27,390 | $1,014 |
| Entresto | 11 | $19,050 | $1,732 |
See all 58 drugs
| Eliquis | 410 | $544,142 | $1,327 |
| Repatha Sureclick | 79 | $78,594 | $995 |
| Jardiance | 33 | $33,571 | $1,017 |
| Xarelto | 27 | $27,390 | $1,014 |
| Entresto | 11 | $19,050 | $1,732 |
| Rosuvastatin | 388 | $6,224 | $16 |
| Metoprolol | 333 | $5,465 | $16 |
| Ezetimibe | 157 | $5,192 | $33 |
| Atorvastatin | 427 | $4,807 | $11 |
| Diltiazem 24hr Er (Cd) | 98 | $4,211 | $43 |
| Valsartan | 122 | $3,682 | $30 |
| Carvedilol | 235 | $3,400 | $14 |
| Losartan | 246 | $3,330 | $14 |
| Amlodipine Besylate | 374 | $2,680 | $7 |
| Flecainide Acetate | 37 | $2,397 | $65 |
| Olmesartan Medoxomil | 73 | $2,034 | $28 |
| Spironolactone | 177 | $1,787 | $10 |
| Potassium Chloride | 94 | $1,668 | $18 |
| Tamsulosin | 58 | $1,139 | $20 |
| Dofetilide | 21 | $1,075 | $51 |
| Midodrine | 17 | $1,061 | $62 |
| Torsemide | 54 | $1,044 | $19 |
| Telmisartan | 11 | $984 | $89 |
| Furosemide | 140 | $979 | $7 |
| Fenofibrate | 17 | $945 | $56 |
| Irbesartan | 45 | $908 | $20 |
| Clopidogrel | 32 | $900 | $28 |
| Sotalol | 40 | $896 | $22 |
| Fludrocortisone Acetate | 31 | $798 | $26 |
| Lisinopril | 54 | $655 | $12 |
| Hydrochlorothiazide | 126 | $577 | $5 |
| Digoxin | 22 | $539 | $25 |
| Levothyroxine | 41 | $532 | $13 |
| Metformin | 41 | $508 | $12 |
| Allopurinol | 23 | $503 | $22 |
| Propafenone | 15 | $448 | $30 |
| Benazepril | 30 | $447 | $15 |
| Metoprolol | 67 | $433 | $6 |
| Valsartan-Hydrochlorothiazide | 22 | $398 | $18 |
| Colchicine | 11 | $387 | $35 |
| Klor-Con 10 | 12 | $372 | $31 |
| Losartan-Hydrochlorothiazide | 22 | $364 | $17 |
| Clonidine | 22 | $364 | $17 |
| Amiodarone | 28 | $349 | $12 |
| Simvastatin | 21 | $301 | $14 |
| Triamterene-Hydrochlorothiazid | 30 | $293 | $10 |
| Warfarin | 14 | $255 | $18 |
| Pantoprazole | 13 | $230 | $18 |
| Ramipril | 13 | $200 | $15 |
| Metformin Hcl Er | 19 | $184 | $10 |
| Finasteride | 15 | $170 | $11 |
| Sertraline | 12 | $104 | $9 |
| Pravastatin | 11 | $79 | $7 |
| Trazodone | 11 | $61 | $6 |
| Atenolol | 13 | $55 | $4 |
| Omeprazole | 21 | $43 | $2 |
| Amoxicillin | 12 | $16 | $1 |
| Lisinopril-Hydrochlorothiazide | 11 | $10 | $1 |
Year by year
| 2024 | 4,819 | 529 | 0% (0) | 14% | $798,990 |
| 2023 | 4,648 | 502 | 0% (0) | 13% | $778,071 |
| 2022 | 4,446 | 467 | 0% (0) | None | $680,904 |
| 2021 | 3,821 | 387 | None | 16% | $552,679 |
| 2020 | 3,853 | 367 | 0% (0) | 19% | $558,149 |
| 2019 | 3,786 | 361 | None | 18% | $494,648 |
| 2018 | 3,415 | 345 | None | 18% | $433,278 |
| 2017 | 3,348 | 331 | 0% (0) | 26% | $457,346 |
| 2016 | 3,047 | 292 | None | 28% | $374,383 |
| 2015 | 3,023 | 268 | None | None | $331,401 |
| 2014 | 3,498 | 254 | None | None | $317,804 |
| 2013 | 3,297 | 251 | None | 36% | $281,965 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 54 drugs
| Eliquis | 394 | $508,926 | $1,292 |
| Repatha Sureclick | 46 | $53,781 | $1,169 |
| Xarelto | 27 | $29,375 | $1,088 |
| Praluent | 27 | $23,070 | $854 |
| Entresto | 13 | $21,002 | $1,616 |
| Jardiance | 16 | $9,001 | $563 |
| Rosuvastatin | 301 | $8,240 | $27 |
| Metoprolol | 365 | $6,853 | $19 |
| Atorvastatin | 458 | $6,241 | $14 |
| Ezetimibe | 125 | $6,195 | $50 |
| Losartan | 261 | $5,020 | $19 |
| Carvedilol | 251 | $4,688 | $19 |
| Diltiazem 24hr Er (Cd) | 69 | $4,239 | $61 |
| Valsartan | 94 | $4,151 | $44 |
| Dofetilide | 23 | $3,804 | $165 |
| Olmesartan Medoxomil | 59 | $3,268 | $55 |
| Amlodipine Besylate | 368 | $2,766 | $8 |
| Midodrine | 18 | $2,713 | $151 |
| Flecainide Acetate | 31 | $2,175 | $70 |
| Potassium Chloride | 88 | $2,153 | $24 |
| Spironolactone | 166 | $2,070 | $12 |
| Irbesartan | 48 | $1,587 | $33 |
| Tamsulosin | 51 | $1,293 | $25 |
| Furosemide | 152 | $1,198 | $8 |
| Sotalol | 33 | $1,003 | $30 |
| Digoxin | 25 | $854 | $34 |
| Propafenone | 16 | $849 | $53 |
| Clopidogrel | 39 | $846 | $22 |
| Clonidine | 37 | $840 | $23 |
| Fludrocortisone Acetate | 28 | $840 | $30 |
| Lisinopril | 63 | $821 | $13 |
| Nebivolol | 12 | $800 | $67 |
| Levothyroxine | 50 | $763 | $15 |
| Klor-Con 10 | 18 | $745 | $41 |
| Warfarin | 31 | $686 | $22 |
| Hydralazine | 19 | $624 | $33 |
| Torsemide | 34 | $587 | $17 |
| Telmisartan | 13 | $559 | $43 |
| Hydrochlorothiazide | 109 | $531 | $5 |
| Metoprolol | 48 | $500 | $10 |
| Metformin | 46 | $481 | $10 |
| Fenofibrate | 17 | $478 | $28 |
| Pantoprazole | 12 | $417 | $35 |
| Amiodarone | 25 | $353 | $14 |
| Triamterene-Hydrochlorothiazid | 25 | $298 | $12 |
| Valsartan-Hydrochlorothiazide | 18 | $284 | $16 |
| Allopurinol | 16 | $264 | $17 |
| Benazepril | 28 | $232 | $8 |
| Metformin Hcl Er | 22 | $147 | $7 |
| Ramipril | 11 | $146 | $13 |
| Simvastatin | 16 | $85 | $5 |
| Atenolol | 11 | $74 | $7 |
| Omeprazole | 21 | $47 | $2 |
| Amoxicillin | 12 | $18 | $2 |
2022: 58 drugs
| Eliquis | 382 | $420,459 | $1,101 |
| Repatha Sureclick | 44 | $38,734 | $880 |
| Xarelto | 16 | $21,770 | $1,361 |
| Corlanor | 16 | $19,239 | $1,202 |
| Praluent | 12 | $15,916 | $1,326 |
| Rosuvastatin | 284 | $15,019 | $53 |
| Dofetilide | 48 | $12,348 | $257 |
| Pradaxa | 12 | $10,975 | $915 |
| Jardiance | 13 | $8,712 | $670 |
| Ezetimibe | 119 | $7,386 | $62 |
| Metoprolol | 358 | $6,439 | $18 |
| Atorvastatin | 376 | $5,470 | $15 |
| Valsartan | 89 | $4,647 | $52 |
| Diltiazem 24hr Er (Cd) | 70 | $3,620 | $52 |
| Olmesartan Medoxomil | 52 | $3,548 | $68 |
| Losartan | 203 | $3,393 | $17 |
| Carvedilol | 213 | $3,314 | $16 |
| Potassium Chloride | 97 | $2,770 | $29 |
| Flecainide Acetate | 32 | $2,720 | $85 |
| Amlodipine Besylate | 403 | $2,248 | $6 |
| Irbesartan | 53 | $1,913 | $36 |
| Propafenone | 23 | $1,827 | $79 |
| Amlodipine-Valsartan | 17 | $1,699 | $100 |
| Fenofibrate | 19 | $1,679 | $88 |
| Fenofibric Acid | 12 | $1,599 | $133 |
| Spironolactone | 153 | $1,571 | $10 |
| Midodrine | 11 | $1,384 | $126 |
| Digoxin | 36 | $1,170 | $33 |
| Furosemide | 184 | $1,055 | $6 |
| Clonidine | 66 | $1,041 | $16 |
| Sotalol | 47 | $930 | $20 |
| Tamsulosin | 48 | $864 | $18 |
| Clopidogrel | 46 | $817 | $18 |
| Benazepril | 24 | $804 | $34 |
| Torsemide | 24 | $724 | $30 |
| Levothyroxine | 25 | $669 | $27 |
| Hydralazine | 20 | $644 | $32 |
| Pantoprazole | 17 | $618 | $36 |
| Hydrochlorothiazide | 109 | $598 | $5 |
| Lisinopril | 45 | $550 | $12 |
| Fludrocortisone Acetate | 27 | $526 | $19 |
| Klor-Con 10 | 22 | $464 | $21 |
| Metformin | 46 | $447 | $10 |
| Amiodarone | 21 | $445 | $21 |
| Propranolol | 11 | $429 | $39 |
| Warfarin | 24 | $335 | $14 |
| Triamterene-Hydrochlorothiazid | 24 | $331 | $14 |
| Finasteride | 13 | $281 | $22 |
| Metoprolol | 33 | $280 | $8 |
| Ramipril | 11 | $185 | $17 |
| Doxazosin Mesylate | 12 | $177 | $15 |
| Sertraline | 15 | $161 | $11 |
| Simvastatin | 26 | $145 | $6 |
| Allopurinol | 13 | $137 | $11 |
| Nitroglycerin | 13 | $130 | $10 |
| Omeprazole | 14 | $130 | $9 |
| Metformin Hcl Er | 11 | $77 | $7 |
| Pravastatin | 13 | $48 | $4 |
2021: 50 drugs
| Eliquis | 304 | $313,998 | $1,033 |
| Repatha Sureclick | 55 | $31,400 | $571 |
| Praluent | 19 | $15,805 | $832 |
| Pradaxa | 17 | $13,759 | $809 |
| Dofetilide | 27 | $13,011 | $482 |
| Rosuvastatin | 208 | $8,398 | $40 |
| Bystolic | 22 | $7,222 | $328 |
| Ezetimibe | 103 | $6,645 | $65 |
| Atorvastatin | 376 | $6,250 | $17 |
| Metoprolol | 268 | $5,816 | $22 |
| Valsartan | 84 | $5,530 | $66 |
| Olmesartan Medoxomil | 39 | $4,726 | $121 |
| Diltiazem 24hr Er (Cd) | 68 | $3,580 | $53 |
| Flecainide Acetate | 31 | $3,190 | $103 |
| Carvedilol | 192 | $2,658 | $14 |
| Losartan | 149 | $2,240 | $15 |
| Amlodipine Besylate | 366 | $2,206 | $6 |
| Fenofibric Acid | 16 | $2,034 | $127 |
| Irbesartan | 59 | $1,854 | $31 |
| Fenofibrate | 20 | $1,471 | $74 |
| Potassium Chloride | 71 | $1,468 | $21 |
| Sotalol | 32 | $1,264 | $40 |
| Spironolactone | 134 | $1,248 | $9 |
| Propafenone | 13 | $1,214 | $93 |
| Lisinopril | 76 | $1,084 | $14 |
| Furosemide | 168 | $946 | $6 |
| Digoxin | 14 | $926 | $66 |
| Hydralazine | 22 | $849 | $39 |
| Levothyroxine | 33 | $818 | $25 |
| Hydrochlorothiazide | 96 | $790 | $8 |
| Diltiazem 24hr Er | 16 | $752 | $47 |
| Benazepril | 25 | $734 | $29 |
| Clopidogrel | 39 | $700 | $18 |
| Klor-Con 10 | 20 | $666 | $33 |
| Fenofibrate | 11 | $559 | $51 |
| Warfarin | 23 | $507 | $22 |
| Metformin | 44 | $459 | $10 |
| Torsemide | 17 | $454 | $27 |
| Triamterene-Hydrochlorothiazid | 26 | $448 | $17 |
| Clonidine | 26 | $434 | $17 |
| Fludrocortisone Acetate | 22 | $321 | $15 |
| Tamsulosin | 31 | $305 | $10 |
| Amlodipine Besylate-Benazepril | 16 | $271 | $17 |
| Ramipril | 12 | $229 | $19 |
| Metoprolol | 31 | $168 | $5 |
| Lovastatin | 12 | $134 | $11 |
| Sertraline | 13 | $113 | $9 |
| Amiodarone | 18 | $111 | $6 |
| Metformin Hcl Er | 13 | $82 | $6 |
| Simvastatin | 19 | $44 | $2 |
2020: 51 drugs
| Eliquis | 335 | $300,858 | $898 |
| Xarelto | 21 | $25,579 | $1,218 |
| Repatha Sureclick | 45 | $24,472 | $544 |
| Dofetilide | 28 | $13,071 | $467 |
| Pradaxa | 17 | $11,012 | $648 |
| Rosuvastatin | 170 | $10,535 | $62 |
| Ezetimibe | 108 | $9,928 | $92 |
| Praluent | 19 | $9,519 | $501 |
| Atorvastatin | 429 | $8,501 | $20 |
| Bystolic | 27 | $8,215 | $304 |
| Edarbi | 11 | $5,665 | $515 |
| Metoprolol | 238 | $5,267 | $22 |
| Valsartan | 58 | $5,208 | $90 |
| Olmesartan Medoxomil | 54 | $4,404 | $82 |
| Flecainide Acetate | 22 | $4,162 | $189 |
| Diltiazem 24hr Er (Cd) | 75 | $3,582 | $48 |
| Irbesartan | 49 | $2,743 | $56 |
| Carvedilol | 208 | $2,709 | $13 |
| Amlodipine Besylate | 331 | $2,288 | $7 |
| Fenofibric Acid | 16 | $2,254 | $141 |
| Sotalol | 51 | $1,945 | $38 |
| Losartan | 125 | $1,876 | $15 |
| Potassium Chloride | 64 | $1,655 | $26 |
| Propafenone | 28 | $1,494 | $53 |
| Spironolactone | 136 | $1,274 | $9 |
| Furosemide | 157 | $1,064 | $7 |
| Cartia Xt | 25 | $1,059 | $42 |
| Hydralazine | 32 | $923 | $29 |
| Fenofibrate | 14 | $913 | $65 |
| Levothyroxine | 30 | $820 | $27 |
| Lisinopril | 80 | $788 | $10 |
| Clopidogrel | 57 | $778 | $14 |
| Digoxin | 21 | $776 | $37 |
| Benazepril | 26 | $676 | $26 |
| Klor-Con 10 | 13 | $675 | $52 |
| Hydrochlorothiazide | 82 | $637 | $8 |
| Propranolol | 12 | $589 | $49 |
| Warfarin | 27 | $520 | $19 |
| Sotalol Af | 11 | $500 | $45 |
| Triamterene-Hydrochlorothiazid | 26 | $482 | $19 |
| Tamsulosin | 27 | $474 | $18 |
| Clonidine | 39 | $418 | $11 |
| Metformin | 30 | $319 | $11 |
| Amiodarone | 27 | $314 | $12 |
| Amlodipine Besylate-Benazepril | 12 | $227 | $19 |
| Ramipril | 14 | $207 | $15 |
| Metoprolol | 29 | $188 | $6 |
| Sertraline | 20 | $145 | $7 |
| Torsemide | 11 | $128 | $12 |
| Atenolol | 12 | $109 | $9 |
| Simvastatin | 16 | $98 | $6 |
2019: 56 drugs
| Eliquis | 283 | $224,820 | $794 |
| Xarelto | 32 | $35,767 | $1,118 |
| Dofetilide | 35 | $26,396 | $754 |
| Propafenone Hcl Er | 18 | $13,421 | $746 |
| Repatha Sureclick | 18 | $12,373 | $687 |
| Entresto | 12 | $11,988 | $999 |
| Corlanor | 15 | $10,895 | $726 |
| Pradaxa | 17 | $10,630 | $625 |
| Atorvastatin | 451 | $9,748 | $22 |
| Rosuvastatin | 129 | $9,327 | $72 |
| Multaq | 11 | $7,403 | $673 |
| Metoprolol | 247 | $7,203 | $29 |
| Ezetimibe | 76 | $5,364 | $71 |
| Bystolic | 20 | $5,278 | $264 |
| Edarbi | 11 | $5,077 | $462 |
| Diltiazem 24hr Er (Cd) | 64 | $4,552 | $71 |
| Valsartan | 59 | $3,782 | $64 |
| Carvedilol | 237 | $3,029 | $13 |
| Flecainide Acetate | 22 | $2,708 | $123 |
| Amlodipine Besylate | 320 | $2,641 | $8 |
| Ranolazine Er | 11 | $2,578 | $234 |
| Potassium Chloride | 103 | $2,505 | $24 |
| Olmesartan Medoxomil | 40 | $2,376 | $59 |
| Eplerenone | 15 | $2,240 | $149 |
| Irbesartan | 50 | $2,215 | $44 |
| Losartan | 107 | $1,728 | $16 |
| Amlodipine Besylate-Benazepril | 23 | $1,402 | $61 |
| Propafenone | 28 | $1,296 | $46 |
| Cartia Xt | 34 | $1,292 | $38 |
| Fenofibrate | 12 | $1,217 | $101 |
| Spironolactone | 119 | $1,117 | $9 |
| Sotalol | 37 | $1,083 | $29 |
| Fenofibrate | 11 | $1,042 | $95 |
| Lisinopril | 88 | $892 | $10 |
| Digoxin | 21 | $870 | $41 |
| Hydrochlorothiazide | 93 | $828 | $9 |
| Klor-Con 10 | 15 | $772 | $51 |
| Warfarin | 40 | $760 | $19 |
| Furosemide | 126 | $690 | $5 |
| Benazepril | 23 | $635 | $28 |
| Enalapril Maleate | 12 | $626 | $52 |
| Hydralazine | 28 | $625 | $22 |
| Metoprolol | 56 | $607 | $11 |
| Clopidogrel | 32 | $588 | $18 |
| Metformin | 27 | $537 | $20 |
| Levothyroxine | 18 | $536 | $30 |
| Propranolol | 18 | $492 | $27 |
| Clonidine | 40 | $474 | $12 |
| Spironolactone-Hctz | 11 | $432 | $39 |
| Tamsulosin | 35 | $366 | $10 |
| Amiodarone | 23 | $354 | $15 |
| Ramipril | 18 | $301 | $17 |
| Triamterene-Hydrochlorothiazid | 21 | $287 | $14 |
| Sertraline | 16 | $178 | $11 |
| Metformin Hcl Er | 12 | $146 | $12 |
| Simvastatin | 18 | $145 | $8 |
2018: 53 drugs
| Eliquis | 253 | $189,950 | $751 |
| Xarelto | 45 | $41,857 | $930 |
| Dofetilide | 29 | $18,260 | $630 |
| Pradaxa | 20 | $15,000 | $750 |
| Propafenone Hcl Er | 13 | $10,430 | $802 |
| Atorvastatin | 392 | $9,116 | $23 |
| Bystolic | 29 | $7,530 | $260 |
| Ezetimibe | 51 | $6,406 | $126 |
| Metoprolol | 211 | $6,370 | $30 |
| Rosuvastatin | 95 | $5,300 | $56 |
| Valsartan | 119 | $4,470 | $38 |
| Ezetimibe-Simvastatin | 12 | $4,178 | $348 |
| Carvedilol Er | 11 | $3,910 | $355 |
| Amlodipine Besylate | 282 | $2,723 | $10 |
| Flecainide Acetate | 18 | $2,719 | $151 |
| Fenofibric Acid | 13 | $2,562 | $197 |
| Olmesartan Medoxomil | 39 | $2,438 | $63 |
| Carvedilol | 197 | $2,394 | $12 |
| Potassium Chloride | 74 | $2,031 | $27 |
| Diltiazem 24hr Er (Cd) | 54 | $1,780 | $33 |
| Fenofibrate | 11 | $1,418 | $129 |
| Propafenone | 26 | $1,407 | $54 |
| Amlodipine Besylate-Benazepril | 22 | $1,364 | $62 |
| Warfarin | 37 | $1,271 | $34 |
| Irbesartan | 41 | $1,194 | $29 |
| Spironolactone | 109 | $1,045 | $10 |
| Fenofibrate | 19 | $1,044 | $55 |
| Valsartan-Hydrochlorothiazide | 20 | $1,032 | $52 |
| Cartia Xt | 44 | $988 | $22 |
| Lisinopril | 103 | $981 | $10 |
| Losartan | 67 | $972 | $15 |
| Digoxin | 23 | $889 | $39 |
| Klor-Con 10 | 15 | $836 | $56 |
| Hydrochlorothiazide | 86 | $740 | $9 |
| Sotalol | 23 | $602 | $26 |
| Hydralazine | 29 | $582 | $20 |
| Omeprazole | 13 | $498 | $38 |
| Benazepril | 17 | $466 | $27 |
| Clopidogrel | 32 | $462 | $14 |
| Tamsulosin | 16 | $432 | $27 |
| Metformin | 36 | $430 | $12 |
| Furosemide | 97 | $417 | $4 |
| Metoprolol | 46 | $327 | $7 |
| Ramipril | 15 | $309 | $21 |
| Levothyroxine | 12 | $283 | $24 |
| Amiodarone | 14 | $273 | $19 |
| Simvastatin | 17 | $245 | $14 |
| Fludrocortisone Acetate | 19 | $201 | $11 |
| Triamterene-Hydrochlorothiazid | 12 | $200 | $17 |
| Clonidine | 39 | $195 | $5 |
| Metformin Hcl Er | 16 | $147 | $9 |
| Atenolol | 11 | $103 | $9 |
| Alprazolam | 11 | $56 | $5 |
2017: 58 drugs
| Eliquis | 278 | $178,334 | $641 |
| Dofetilide | 42 | $39,172 | $933 |
| Xarelto | 32 | $31,336 | $979 |
| Pradaxa | 24 | $15,581 | $649 |
| Propafenone Hcl Er | 13 | $12,321 | $948 |
| Coreg Cr | 12 | $9,199 | $767 |
| Zetia | 16 | $8,867 | $554 |
| Ranexa | 13 | $8,533 | $656 |
| Atorvastatin | 367 | $7,544 | $21 |
| Bystolic | 32 | $6,811 | $213 |
| Ezetimibe | 23 | $6,138 | $267 |
| Brilinta | 18 | $5,997 | $333 |
| Rosuvastatin | 78 | $5,300 | $68 |
| Metoprolol | 152 | $5,235 | $34 |
| Entresto | 11 | $4,695 | $427 |
| Valsartan | 123 | $3,538 | $29 |
| Fenofibric Acid | 21 | $3,389 | $161 |
| Diltiazem 24hr Er | 102 | $3,053 | $30 |
| Flecainide Acetate | 32 | $2,986 | $93 |
| Carvedilol | 179 | $2,319 | $13 |
| Potassium Chloride | 79 | $2,306 | $29 |
| Eplerenone | 11 | $2,041 | $186 |
| Amlodipine Besylate | 210 | $1,968 | $9 |
| Valsartan-Hydrochlorothiazide | 30 | $1,129 | $38 |
| Propafenone | 26 | $1,106 | $43 |
| Klor-Con 10 | 13 | $1,057 | $81 |
| Spironolactone | 117 | $1,042 | $9 |
| Fenofibrate | 25 | $858 | $34 |
| Lisinopril | 99 | $810 | $8 |
| Amlodipine Besylate-Benazepril | 12 | $765 | $64 |
| Amiodarone | 37 | $700 | $19 |
| Warfarin | 25 | $685 | $27 |
| Clopidogrel | 26 | $677 | $26 |
| Irbesartan | 17 | $669 | $39 |
| Furosemide | 131 | $597 | $5 |
| Cartia Xt | 33 | $589 | $18 |
| Torsemide | 36 | $579 | $16 |
| Simvastatin | 29 | $532 | $18 |
| Losartan | 39 | $502 | $13 |
| Sotalol | 25 | $493 | $20 |
| Hydrochlorothiazide | 54 | $491 | $9 |
| Digoxin | 20 | $482 | $24 |
| Levothyroxine | 16 | $466 | $29 |
| Hydralazine | 24 | $436 | $18 |
| Omeprazole | 18 | $405 | $23 |
| Midodrine | 12 | $367 | $31 |
| Enalapril Maleate | 11 | $321 | $29 |
| Metoprolol | 43 | $315 | $7 |
| Ramipril | 26 | $313 | $12 |
| Benazepril | 21 | $295 | $14 |
| Triamterene-Hydrochlorothiazid | 18 | $275 | $15 |
| Fludrocortisone Acetate | 29 | $273 | $9 |
| Metformin | 32 | $262 | $8 |
| Tamsulosin | 18 | $216 | $12 |
| Clonidine | 31 | $195 | $6 |
| Lovastatin | 16 | $153 | $10 |
| Metformin Hcl Er | 15 | $99 | $7 |
| Alprazolam | 16 | $80 | $5 |
2016: 55 drugs
| Eliquis | 239 | $127,058 | $532 |
| Xarelto | 31 | $25,047 | $808 |
| Tikosyn | 25 | $21,349 | $854 |
| Zetia | 27 | $15,901 | $589 |
| Crestor | 44 | $15,476 | $352 |
| Pradaxa | 22 | $13,334 | $606 |
| Coreg Cr | 22 | $11,784 | $536 |
| Valsartan | 96 | $7,217 | $75 |
| Atorvastatin | 280 | $7,123 | $25 |
| Vytorin | 16 | $7,008 | $438 |
| Benicar | 11 | $5,921 | $538 |
| Metoprolol | 135 | $5,081 | $38 |
| Celebrex | 12 | $3,496 | $291 |
| Midodrine | 62 | $3,291 | $53 |
| Diltiazem 24hr Er | 72 | $3,049 | $42 |
| Fenofibric Acid | 24 | $2,953 | $123 |
| Potassium Chloride | 97 | $2,523 | $26 |
| Bystolic | 19 | $2,429 | $128 |
| Flecainide Acetate | 23 | $2,343 | $102 |
| Rosuvastatin | 27 | $2,247 | $83 |
| Carvedilol | 181 | $1,984 | $11 |
| Tamsulosin | 48 | $1,543 | $32 |
| Propafenone | 35 | $1,457 | $42 |
| Amlodipine Besylate | 162 | $1,357 | $8 |
| Klor-Con 10 | 19 | $1,331 | $70 |
| Valsartan-Hydrochlorothiazide | 27 | $952 | $35 |
| Lisinopril | 94 | $872 | $9 |
| Warfarin | 28 | $841 | $30 |
| Amiodarone | 41 | $837 | $20 |
| Levothyroxine | 23 | $821 | $36 |
| Clopidogrel | 32 | $768 | $24 |
| Spironolactone | 80 | $764 | $10 |
| Fenofibrate | 14 | $723 | $52 |
| Furosemide | 128 | $692 | $5 |
| Irbesartan | 24 | $676 | $28 |
| Sotalol | 34 | $593 | $17 |
| Torsemide | 34 | $508 | $15 |
| Hydrochlorothiazide | 51 | $465 | $9 |
| Ramipril | 25 | $459 | $18 |
| Hydralazine | 15 | $455 | $30 |
| Losartan | 41 | $455 | $11 |
| Simvastatin | 43 | $449 | $10 |
| Sotalol Af | 14 | $399 | $29 |
| Omeprazole | 23 | $394 | $17 |
| Digoxin | 16 | $385 | $24 |
| Metoprolol | 43 | $275 | $6 |
| Lovastatin | 23 | $209 | $9 |
| Jantoven | 12 | $177 | $15 |
| Metformin | 21 | $168 | $8 |
| Fludrocortisone Acetate | 29 | $137 | $5 |
| Benazepril | 14 | $129 | $9 |
| Clonidine | 11 | $119 | $11 |
| Triamterene-Hydrochlorothiazid | 16 | $99 | $6 |
| Alprazolam | 13 | $97 | $7 |
| Metformin Hcl Er | 20 | $96 | $5 |
2015: 54 drugs
| Eliquis | 180 | $80,415 | $447 |
| Tikosyn | 50 | $33,751 | $675 |
| Xarelto | 41 | $30,974 | $755 |
| Crestor | 68 | $16,911 | $249 |
| Coreg Cr | 33 | $13,918 | $422 |
| Pradaxa | 25 | $12,782 | $511 |
| Valsartan | 88 | $11,738 | $133 |
| Vytorin | 18 | $7,625 | $424 |
| Benicar | 19 | $7,247 | $381 |
| Atorvastatin | 282 | $6,398 | $23 |
| Metoprolol | 156 | $5,743 | $37 |
| Fenofibric Acid | 29 | $5,214 | $180 |
| Diovan | 11 | $4,906 | $446 |
| Edarbi | 14 | $3,648 | $261 |
| Potassium Chloride | 118 | $3,527 | $30 |
| Flecainide Acetate | 21 | $3,477 | $166 |
| Celebrex | 11 | $2,698 | $245 |
| Midodrine | 27 | $2,667 | $99 |
| Carvedilol | 207 | $2,277 | $11 |
| Fenofibrate | 12 | $1,901 | $158 |
| Valsartan-Hydrochlorothiazide | 28 | $1,651 | $59 |
| Eplerenone | 13 | $1,580 | $122 |
| Warfarin | 51 | $1,529 | $30 |
| Diltiazem 24hr Er | 35 | $1,422 | $41 |
| Tamsulosin | 31 | $1,212 | $39 |
| Amlodipine Besylate | 181 | $1,205 | $7 |
| Diltiazem 24hr Cd | 18 | $1,160 | $64 |
| Diltiazem 12hr Er | 13 | $1,034 | $80 |
| Fenofibrate | 11 | $1,028 | $93 |
| Klor-Con 10 | 11 | $980 | $89 |
| Sotalol | 43 | $869 | $20 |
| Propafenone | 23 | $851 | $37 |
| Lisinopril | 115 | $759 | $7 |
| Irbesartan | 37 | $736 | $20 |
| Furosemide | 133 | $710 | $5 |
| Fenofibrate | 11 | $622 | $57 |
| Amiodarone | 59 | $606 | $10 |
| Losartan | 47 | $563 | $12 |
| Levothyroxine | 25 | $517 | $21 |
| Hydrochlorothiazide | 58 | $499 | $9 |
| Cartia Xt | 14 | $474 | $34 |
| Ramipril | 33 | $473 | $14 |
| Allopurinol | 15 | $435 | $29 |
| Spironolactone | 57 | $410 | $7 |
| Toprol Xl | 14 | $388 | $28 |
| Clopidogrel | 23 | $358 | $16 |
| Simvastatin | 27 | $321 | $12 |
| Metoprolol | 46 | $304 | $7 |
| Hydralazine | 16 | $300 | $19 |
| Omeprazole | 14 | $295 | $21 |
| Clonidine | 18 | $262 | $15 |
| Metformin | 33 | $248 | $8 |
| Lovastatin | 11 | $92 | $8 |
| Metformin Hcl Er | 18 | $48 | $3 |
2014: 56 drugs
| Eliquis | 107 | $40,930 | $383 |
| Xarelto | 72 | $36,258 | $504 |
| Diovan | 85 | $24,028 | $283 |
| Tikosyn | 57 | $21,899 | $384 |
| Pradaxa | 35 | $15,395 | $440 |
| Coreg Cr | 60 | $13,693 | $228 |
| Valsartan | 55 | $12,091 | $220 |
| Crestor | 45 | $11,054 | $246 |
| Vytorin | 25 | $9,460 | $378 |
| Atorvastatin | 335 | $8,665 | $26 |
| Zetia | 19 | $7,301 | $384 |
| Fenofibric Acid | 44 | $7,134 | $162 |
| Celebrex | 11 | $6,990 | $635 |
| Januvia | 15 | $6,043 | $403 |
| Metoprolol | 147 | $5,664 | $39 |
| Potassium Chloride | 124 | $4,015 | $32 |
| Fenofibrate | 13 | $3,330 | $256 |
| Carvedilol | 277 | $3,281 | $12 |
| Valsartan-Hydrochlorothiazide | 43 | $2,981 | $69 |
| Edarbi | 17 | $2,947 | $173 |
| Bystolic | 17 | $2,833 | $167 |
| Midodrine | 11 | $2,022 | $184 |
| Warfarin | 86 | $1,797 | $21 |
| Flecainide Acetate | 26 | $1,680 | $65 |
| Amlodipine Besylate | 208 | $1,546 | $7 |
| Propafenone | 30 | $1,495 | $50 |
| Diltiazem 24hr Er | 33 | $1,228 | $37 |
| Klor-Con 10 | 16 | $1,067 | $67 |
| Sotalol | 41 | $1,064 | $26 |
| Losartan | 54 | $922 | $17 |
| Clopidogrel | 50 | $904 | $18 |
| Lisinopril | 113 | $880 | $8 |
| Levothyroxine | 58 | $858 | $15 |
| Diltiazem 12hr Er | 16 | $857 | $54 |
| Torsemide | 19 | $772 | $41 |
| Tamsulosin | 30 | $761 | $25 |
| Omeprazole | 36 | $736 | $20 |
| Ramipril | 33 | $633 | $19 |
| Hydrochlorothiazide | 72 | $630 | $9 |
| Toprol Xl | 13 | $577 | $44 |
| Simvastatin | 72 | $560 | $8 |
| Furosemide | 153 | $560 | $4 |
| Metformin | 52 | $527 | $10 |
| Digox | 11 | $509 | $46 |
| Amiodarone | 41 | $476 | $12 |
| Pantoprazole | 12 | $448 | $37 |
| Spironolactone | 56 | $382 | $7 |
| Propranolol Hcl Er | 11 | $341 | $31 |
| Allopurinol | 26 | $309 | $12 |
| Clonidine | 17 | $278 | $16 |
| Zolpidem | 14 | $247 | $18 |
| Metoprolol | 24 | $226 | $9 |
| Triamterene-Hydrochlorothiazid | 11 | $184 | $17 |
| Alprazolam | 24 | $149 | $6 |
| Glyburide | 12 | $86 | $7 |
| Clonazepam | 12 | $22 | $2 |
2013: 60 drugs
| Diovan | 105 | $25,680 | $245 |
| Xarelto | 64 | $24,643 | $385 |
| Pradaxa | 51 | $22,956 | $450 |
| Vytorin | 53 | $17,216 | $325 |
| Tikosyn | 54 | $13,505 | $250 |
| Coreg Cr | 57 | $12,766 | $224 |
| Zetia | 44 | $12,107 | $275 |
| Atorvastatin | 265 | $9,650 | $36 |
| Niaspan | 17 | $7,440 | $438 |
| Fenofibrate | 32 | $7,012 | $219 |
| Trilipix | 28 | $6,726 | $240 |
| Metoprolol | 134 | $6,313 | $47 |
| Lipitor | 13 | $6,093 | $469 |
| Crestor | 24 | $5,878 | $245 |
| Multaq | 14 | $4,518 | $323 |
| Welchol | 13 | $4,072 | $313 |
| Carvedilol | 262 | $3,800 | $15 |
| Potassium Chloride | 124 | $3,663 | $30 |
| Bystolic | 41 | $3,466 | $85 |
| Valsartan-Hydrochlorothiazide | 48 | $3,339 | $70 |
| Propafenone | 29 | $3,210 | $111 |
| Exforge | 19 | $2,606 | $137 |
| Warfarin | 100 | $2,327 | $23 |
| Diltiazem Er | 21 | $1,775 | $85 |
| Flecainide Acetate | 41 | $1,751 | $43 |
| Clopidogrel | 40 | $1,731 | $43 |
| Diltiazem 24hr Er | 32 | $1,709 | $53 |
| Midodrine | 14 | $1,496 | $107 |
| Amlodipine Besylate | 170 | $1,479 | $9 |
| Fenofibrate | 14 | $1,378 | $98 |
| Losartan | 52 | $1,129 | $22 |
| Simvastatin | 87 | $1,041 | $12 |
| Omeprazole | 35 | $1,014 | $29 |
| Sotalol | 36 | $958 | $27 |
| Klor-Con 10 | 14 | $947 | $68 |
| Ramipril | 33 | $866 | $26 |
| Hydrochlorothiazide | 93 | $834 | $9 |
| Klor-Con M10 | 13 | $779 | $60 |
| Diltiazem 24hr Cd | 16 | $737 | $46 |
| Furosemide | 174 | $682 | $4 |
| Metformin | 47 | $583 | $12 |
| Mexiletine | 13 | $549 | $42 |
| Lisinopril | 44 | $474 | $11 |
| Amiodarone | 37 | $465 | $13 |
| Tamsulosin | 23 | $451 | $20 |
| Levothyroxine | 38 | $442 | $12 |
| Taztia Xt | 13 | $417 | $32 |
| Propranolol | 18 | $384 | $21 |
| Benazepril | 13 | $360 | $28 |
| Spironolactone | 25 | $358 | $14 |
| Triamterene-Hctz | 21 | $344 | $16 |
| Sotalol Af | 19 | $324 | $17 |
| Clonidine | 26 | $324 | $12 |
| Lovastatin | 15 | $251 | $17 |
| Allopurinol | 22 | $211 | $10 |
| Digox | 22 | $168 | $8 |
| Zolpidem | 16 | $89 | $6 |
| Bumetanide | 11 | $80 | $7 |
| Alprazolam | 15 | $62 | $4 |
| Fludrocortisone Acetate | 12 | $52 | $4 |
Money from drug and device companies
$531 in 2025
| 2025 | 3 | 4 | None | $531 |
| 2024 | 1 | 2 | None | $282 |
| 2023 | 2 | 2 | None | $449 |
| 2022 | 1 | 1 | None | $163 |
| 2020 | 4 | 4 | None | $71 |
| 2019 | 16 | 44 | None | $1,106 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $269 | 2 payments
|
| Medtronic | Aurora Ev-Icd Mri Surescan | $164 | 1 payment
|
| W. L. Gore & Associates | Excluder Conformable Aaa Endoprosthesis With Active Control | $98 | 1 payment
|
See all 4 published payments
| W. L. Gore & Associates | Meals · 2025-12-02 | Excluder Conformable Aaa Endoprosthesis With Active Control | $98 |
| AtriCure | Meals · 2025-07-23 | Epi-Sense Guided Coagulation System With Visitrax | $164 |
| AtriCure | Meals · 2025-05-27 | Epi-Sense Guided Coagulation System With Visitrax | $106 |
| Medtronic | Meals · 2025-05-19 | Aurora Ev-Icd Mri Surescan | $164 |
See earlier years (2024, 2023, 2022, 2020, 2019)
2024: $282
| Boston Scientific | Rhythmia Mapping System | $282 | 2 payments
|
2023: $449
| Ablacon | None | $241 | 1 payment
|
| Impulse Dynamics (USA) | Optimizer | $208 | 1 payment
|
2022: $163
| Impulse Dynamics (USA) | Optimizer | $163 | 1 payment
|
2020: $71
| Sanofi-Aventis U.S. | Multaq | $19 | 1 payment
|
| Amgen | Corlanor | $19 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $19 | 1 payment
|
| Novo Nordisk | Ozempic | $14 | 1 payment
|
2019: $1,106
| Amgen | Repatha | $395 | 13 payments
|
| Biotronik | None | $89 | 2 payments
|
| Sanofi-Aventis U.S. | Praluent | $82 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $69 | 4 payments
|
| Canon Medical Systems USA | None | $68 | 1 payment
|
| Regeneron Healthcare Solutions | Praluent | $67 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $51 | 2 payments
|
| Daiichi Sankyo | Injectafer | $48 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $45 | 2 payments
|
| Pfizer | Eliquis | $42 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $41 | 2 payments
|
| Boston Scientific | Watchman | $33 | 2 payments
|
| Lundbeck | Northera | $24 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $22 | 1 payment
|
| Arbor Pharmaceuticals | Edarbi | $19 | 1 payment
|
| Chiesi USA | Kengreal | $12 | 1 payment
|
Professional record
- NPI
- 1386678951
- Licence
- CA C40443California C40443: Current · expires 2027-09-30
- Trained
- University of Texas Medical Branch at Galveston, 1980
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Federal specialty code 207RC0001X (207RC0001X); Federal specialty code 207UN0901X (207UN0901X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-07-10
- NPI last updated
- 2020-05-28
- NPI record certified
- 2020-05-28
This is when the NPI record was last certified, not a medical board exam.